Development and characterization of topical liposomal gel formulation for anti-cellulite activity

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL 3, 2013, Pages 512-516

  Vyas, Lalit K ^a   Tapar, Kiran K ^b   Nema, Rajesh K ^c   Parashar, Ashish K ^c  

^a Vidyabharati Mahavidyalaya ^*  (India)

^b Camp   (India)

^c Rishiraj College of Pharmacy   (India)

Author keywords

Anti cellulite activity; Caffeine; Liposomal gel; Novel drug delivery

Indexed keywords

CAFFEINE; CARBOMER; CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; HYDRATION; LIPID STORAGE; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; PH; RAT; SKIN PERMEABILITY; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL;

EID: 84882798485     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effect of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm 2001; 215: 229-240.
2. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the swollen phospholipids. J Mol Biol 1965; 13: 238-252.
3. Weissmann G, Cohen C, Hoffstein S. Introduction of missing enzymes into the cytoplasm of cultured mammalian cells by mean of fusion-prone liposomes. Trans Assoc Am Phys 1977; 89: 171-183.
4. Moghimi SM, Patel HM. Current progress and future prospects of liposomes in dermal drug delivery. J Microencapsul 1993; 10: 155-162.
5. Cevc G. Transferosomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996; 13: 257-388.
6. Schmid MH, Korting HC. Therapeutic progress with liposome drugs for skin disease. Adv Drug Deliv Rev 1996; 18: 335-342.
7. New, RRC. Liposomes: A Practical Approach. IRC. Oxford; 1990. p. 256-58.
8. Dipali SR, Kulkarni SB, Betagiri GV. Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. J Pharm Pharmacol 1996; 48 (11): 1112-1115.
9. Abdel-Mottaleb MMA, Mortada ND, Elshamy AA, Awad GAS. Preparation and evaluation of fluconazole gels. Egypt J Biomed Sci 2007; 23: 266-286.
10. Glavas-Dodov M. Formulation and characterization of topical liposome gel bearing lidocaine HCl. Bull Chem Tech Macedonia 2005; 24(1): 59-65.
11. Du Plessis J, Ramchandran C, Weiner N, Muller DG. The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 1994; 103: 277-282.
12. Nagarsenker MS. Preparation and evaluation of a liposomal formulation of sodium cromoglicate. Int J Pharm 2003; 251: 49-56.
13. Sorensen EN, Weisman G, Vidaver GA. A sephadex column for measuring uptake and loss of low molecular weight solutes from small vesicles. Anal Biochem 1977; 82: 376-384.
14. Sriram V and Rhodes CT. Preparation and characterization of liposomes as therapeutic delivery systems. A Rev Pharm Acta Hel 1995; 70: 95-111.
15. Predescu I, Simion D, Pirvu C, Popescu ST. Studies on rheological properties of gel of Diclofenac Sod. Farmacia (XLIV). 2001. 5: 58-64.
16. Andrews GP, Donnelly L, Jones DS, Curran RM, Morrow RJ, Woolfson AD, Malcolm RK. Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery. Biomacromol 2009; 10(9): 2427-2435.
17. Bonacucina G, Cespi M, Misici-Falzi M, Palmieri G. Rheological, adhesive and release characterization of semisolid carbopol/tetra glycol systems. Int J Pharm 2006; 307: 129-140.
18. Ortan A, Dinu-Pirvu C, Ghica MV, Popescu LM, Ionita L. Rheological study of a liposomal hydrogel based on carbopol. Rom Biotech Letters 2011; 16 (1): 47-53.
19. Goindi S, Aggarwal N. Preparation of hydrogels of griseofulvin for dermal application. Int J Pharm 2006; 326: 20-24.
20. Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Sci 2004; 7(2): 252-259.
21. Zhao K, Singh S, Singh J. Effect of menthone on the in-vitro percutaneous absorption of tamoxifen and skin reversibility. Int J Pharm 2001; 219: 177-181.
22. Maenpaa J, Dooley T, Wurz G, VandeBerg J, Robinson E, Emshoff V, Sipila P, Wiebe V, Day C, DeGregorio M. Topical toremifine: a new approach for cutaneous melanoma. Cancer Chemother Pharmacol 1993; 32: 392-395.
23. Soe L, Wurz GT, Maenpaa JU, Hubbard GB, Cadman TB, Wiebe VJ, Theon AP, DeGregorio MW. Tissue distribution of transdermal toremifene. Cancer Chemother Pharmacol 1997; 39: 513-520.
24. Shahi S, Sonwane U, Zadbuke N, Tadwee I. Design and development of Dipehnhydramine Hydrochloride topical liposomal drug delivery system. Int J Pharmacy & Pharm Sci 2013; 5(3): 534-542.
25. Konda N, Arvind G, Shah S, Prashant P. Formulation and evaluation of non-PEGylated doxorubicin liposomal drug delivery system. Int J Pharmacy & Pharm Sci 2013; 5(2): 541-547.